60-minute warm-up required when applying the sensor.Ĩ. Dexcom G6 CGM User Guide and Medtronic Guardian Connect System User Guide.ħ. “Accuracy of a 14-Day Factory-Calibrated Continuous Glucose Monitoring System With Advanced Algorithm in Pediatric and Adult Population With Diabetes.” Journal of Diabetes Science and Technology, (September 2020).Ħ. Christiansen, Gregory Forlenza, Mark Kipnes, David R. Alva, Shridhara, Timothy Bailey, Ronald Brazg, Erwin S. Data on file, Abbott Diabetes Care, Inc.ĥ.
#Freestyle libre flash glucose monitoring system class ii b registration#
Use of FreeStyle LibreLink requires registration with LibreView.Ĥ. Please check the website for more information about device compatibility before using the app. The FreeStyle LibreLink app is only compatible with certain mobile devices and operating systems. Once the patient scans their FreeStyle Libre 2 sensor with that device, they can receive alarms only on that device.
They must start their FreeStyle Libre 2 sensor with that selected device. Patients choose which device they want to receive alarms: FreeStyle Libre 2 reader or FreeStyle LibreLink app. Finger pricks are required if your glucose readings and alarms do not match symptoms or expectations.ģ. Data based on the number of users worldwide for the FreeStyle Libre system compared to the number of users for other leading personal use sensor based glucose monitoring systems.Ģ. All rights reserved.Images are for illustrative purposes only. HbA1c cardiovascular flash blood glucose monitoring glycaemic control type 1 diabetes.Ĭopyright © 2020 Wolters Kluwer Health, Inc. The technology provides significantly more data than the intermittent results obtained by traditional subcutaneous blood glucose monitoring, which may not capture intervals of extreme variability or nocturnal events. After the 6-month follow-up, two 2/92 users did not wish to continue with the monitoring.įlash glucose monitoring has great potential for the management of type 1 diabetes in the adult population and improving metabolic control/quality of life for people across the world. There was also a narrowing of the distribution of HbA1c, with many fewer people running high HbA1c ≥80 mmol/mol (9.5%). In 92 consecutive users, HbA1c decreased by an average of 10.7 mmol/mol (0.98%) after 3 months, and by 16.1 mmol/mol (1.47%) after 6 months. The mean cohort age was 43 years for men and 39 years for women (overall range 17-83 years). An HbA1c of 60 mmol/mol (7.6%) was taken as the threshold for suboptimal glycaemic control. Initiation was with education and support from one of the diabetes specialist nurses. We report the outcomes of 92 consecutive adults (18 years of age or more) with type 1 diabetes who have begun using the FreeStyle Libre flash glucose monitor in East Cheshire, UK. We describe here how use of the FreeStyle Libre flash monitor has improved the glycaemic control of many people with type 1 diabetes where the new technology has been intensively deployed. Many people with type 1 diabetes continue to run high HbA1c levels with associated elevated risk of cardiovascular events and increased mortality.
0 kommentar(er)
